Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Alternative perfusion technique without axillary artery cannulation during combined aortic root and total arch replacement.
Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
Improving CKD-Specific Patient-Reported Measures of Health-Related Quality of Life.
Gene-based therapy for alpha-1 antitrypsin deficiency.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gene-based therapy for alpha-1 antitrypsin deficiency.
Mueller C, Flotte TR. Gene-based therapy for alpha-1 antitrypsin deficiency. COPD. 2013 Mar; 10 Suppl 1:44-9.
View in:
PubMed
subject areas
Adenoviridae
alpha 1-Antitrypsin
alpha 1-Antitrypsin Deficiency
Dependovirus
DNA, Recombinant
Genetic Therapy
Genetic Vectors
Humans
Liposomes
RNA, Small Interfering
authors with profiles
Terence R Flotte MD